In rats, CBD (Cannabidiol) has demonstrated inhibition of TNFα in experimentally induced uveitis as well as retinal TNFα release, which could be efficacious in management of autoimmune uveitis, retinal inflammation, and neuroprotection [67]. This evidence concerns the gene TNF and autoimmune uveitis.